Abstract Objective To investigate the effects of reducing the auditory organ dose by limitation of sub regional auditory organ in IMRT plan. Methods Total 223 cases of nasopharyngeal carcinoma patients were divided into group A and group B. In group A, the IMRT plans of 114 patients were designed by limiting overall auditory organ dose. In group B, the IMRT plans of 109 patients were designed by limiting sub regional auditory organ dose. According to the Clinical prescription, the IMRT plans were designed. Paried t-test was difference between groups. Results By comparing the two groups of auditory organ dose, in all stages, the tympanic cavity Dmean average in group B decreased by T1vs. 17.7%,T2vs. 22.4%,T3vs. 15.7% and T4vs. 14.2%(P=0.000,0.000,0.000,0.000);cochlea Dmean average decreased by T1vs. 11.0%, T2vs. 20.1%, T3vs. 10.0% and T4vs. 9.0%(P=0.004,0.000,0.007,0.036);vestibule Dmean average decreased by T1vs. 22.6%, T2vs. 31.8%, T3vs. 20.6% and T4vs. 21.4%, significantly less than in group A (P=0.000,0.000,0.000,0.000). The bony portion of eustachian tube Dmean average in group B decreased were not significantly less than in group A (decreased by 3.4%,6.8%,3.6%,0.1%;P=0.291,0.006,0.155,0.963). Conclusions In IMRT plan, optimization on dose limitation of sub regional auditory organs were used to reduce the auditory organ dose and decrease the radiation damage to auditory organ.
Corresponding Authors:
Wang Shengzi,Email:Shengziwang@fudan.edu.cn
Cite this article:
Guo Ming,Wamg Shengzi,Wu Zhaoxia et al. The research of IMRT plan optimization on dose limitation of sub regional auditory organ[J]. Chinese Journal of Radiation Oncology, 2015, 24(4): 438-441.
Guo Ming,Wamg Shengzi,Wu Zhaoxia et al. The research of IMRT plan optimization on dose limitation of sub regional auditory organ[J]. Chinese Journal of Radiation Oncology, 2015, 24(4): 438-441.
[1] Yeh SA, Tang Y, Lu CC, et al. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone[J]. Int J Radiat Oncol Biol Phys,2005,62(3):672-679. [2] 王胜资,阎小军,郭明,等.鼻咽癌3-D计划放射治疗后放射性中耳炎临床分析[J].中国癌症杂志,2006,16(6):503-507.DOI:10.3969/j.issn.1007-3639.2006.06.021 [3] 何景扬,林瑞蔼,陈国健.3 d计划鼻咽癌放疗后放射性中耳炎临床分析[J].肿瘤基础与临床,2013,26(5):444-445.DOI:10.3969/j.issn.1673-5412.2013.05.026. [4] Wang SZ, Wang WF, Zhang HY, et al. Analysis of anatomical factors controlling the morbidity of radiation-induced otitis media with effusion[J].Radiat Oncol,2007,85(3):463-446. [5] 中国鼻咽癌临床分期工作委员会.2010鼻咽癌IMRT靶区及剂量设计指引专家共识[J].中华放射肿瘤学杂志,2011,20(4):
2015, Vol. 24 
